Alnylam Pharmaceuticals
ALNY
ALNY
185 hedge funds and large institutions have $4.6B invested in Alnylam Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 62 increasing their positions, 69 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
10% less repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 69
19% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 26
Holders
185
Holding in Top 10
9
Calls
$49.7M
Puts
$49M
Top Buyers
| 1 | +$50.8M | |
| 2 | +$27.7M | |
| 3 | +$25.4M | |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$25.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23.9M |
Top Sellers
| 1 | -$39.7M | |
| 2 | -$30.3M | |
| 3 | -$21.7M | |
| 4 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$18M |
| 5 |
CCI
Columbus Circle Investors
|
-$11.7M |